1887

Abstract

Infectious laryngotracheitis (ILT) is a highly contagious respiratory disease of chickens caused by infectious laryngotracheitis virus (ILTV). The disease is controlled by the use of live-attenuated vaccines. Previously we reported the complete nucleotide sequence of the ILTV vaccine strain (TCO) and identified a nonsense mutation in the gene encoding the ORF C protein. This suggested that the ORF C protein might be associated with viral virulence. To investigate this, an ILTV recombinant with a deletion in the gene encoding ORF C was constructed using the genome of the virulent United States Department of Agriculture (USDA) challenge strain (USDAch). Compared to the parental virus, the ΔORF C recombinant replicated in chicken kidney (CK) cells with similar kinetics and generated similar titres. This demonstrated that the ORF C deletion had no deleterious effects on replication efficacy . In chickens, the recombinant induced only minor microscopic tracheal lesions when inoculated via the intra-tracheal/ocular route, while the parental strain induced moderate to severe microscopic tracheal lesions, even though virus load in the tracheas were comparable. Groups of chickens vaccinated via eye-drop with the ∆ORFC-ILTV were protected to levels comparable to those elicited by TCO vaccination. To our knowledge, this is the first report that demonstrates the suitability of ∆ORFC as a live-attenuated vaccine to prevent the losses caused by ILTV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000521
2016-09-01
2020-09-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2352.html?itemId=/content/journal/jgv/10.1099/jgv.0.000521&mimeType=html&fmt=ahah

References

  1. Bagust T. J., Jones R. C., Guy J. S.. 2000; Avian infectious laryngotracheitis. Rev Sci Tech19:483–492
    [Google Scholar]
  2. Davison S., Gingerich E. N., Casavant S., Eckroade R. J.. 2006; Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge. Avian Dis50:50–54 [CrossRef][PubMed]
    [Google Scholar]
  3. Davison A. J.. 2010; Herpesvirus systematics. Vet Microbiol143:52–69 [CrossRef][PubMed]
    [Google Scholar]
  4. Devlin J. M., Browning G. F., Hartley C. A., Kirkpatrick N. C., Mahmoudian A., Noormohammadi A. H., Gilkerson J. R.. 2006; Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J Gen Virol87:2839–2847 [CrossRef][PubMed]
    [Google Scholar]
  5. Devlin J. M., Browning G. F., Hartley C. A., Gilkerson J. R.. 2007; Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine25:3561–3566 [CrossRef][PubMed]
    [Google Scholar]
  6. Devlin J. M., Browning G. F., Gilkerson J. R., Fenton S. P., Hartley C. A.. 2008; Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol. Avian Pathol37:83–88 [CrossRef][PubMed]
    [Google Scholar]
  7. Devlin J. M., Viejo-Borbolla A., Browning G. F., Noormohammadi A. H., Gilkerson J. R., Alcami A., Hartley C. A.. 2010; Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine28:1325–1332 [CrossRef][PubMed]
    [Google Scholar]
  8. Dufour-Zavala L.. 2008; Epizootiology of infectious laryngotracheitis and presentation of an industry control program. Avian Dis52:1–7 [CrossRef][PubMed]
    [Google Scholar]
  9. Fahey K. J., York J. J.. 1990; The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. J Gen Virol71:2401–2405 [CrossRef][PubMed]
    [Google Scholar]
  10. Fuchs W., Ziemann K., Teifke J. P., Werner O., Mettenleiter T. C.. 2000; The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor. J Gen Virol81:627–638 [CrossRef][PubMed]
    [Google Scholar]
  11. Fuchs W., Mettenleiter T. C.. 2005; The nonessential UL49.5 gene of infectious laryngotracheitis virus encodes an O-glycosylated protein which forms a complex with the non-glycosylated UL10 gene product. Virus Res112:108–114 [CrossRef][PubMed]
    [Google Scholar]
  12. Fuchs W., Wiesner D., Veits J., Teifke J. P., Mettenleiter T. C.. 2005; In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. J Virol79:705–716 [CrossRef][PubMed]
    [Google Scholar]
  13. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J. P., Mettenleiter T. C.. 2007; Molecular biology of avian infectious laryngotracheitis virus. Vet Res38:261–279 [CrossRef][PubMed]
    [Google Scholar]
  14. García M., Riblet S. M.. 2001; Characterization of infectious laryngotracheitis virus isolates: demonstration of viral subpopulations within vaccine preparations. Avian Dis45:558–566[PubMed][CrossRef]
    [Google Scholar]
  15. García M., Spatz S., Guy J. S.. 2013a; Laryngotracheitis. In Diseases of Poultry, 13th edn pp161–179 . Edited by Swayne D. E., Glisson J. R., McDougald L. R., Nolan L. K., Suarez D. L., Nair V.. Ames, Iowa: Blackwell Publishing;
    [Google Scholar]
  16. García M., Volkening J., Riblet S., Spatz S.. 2013b; Genomic sequence analysis of the United States infectious laryngotracheitis vaccine strains chicken embryo origin (CEO) and tissue culture origin (TCO). Virology440:64–74 [CrossRef]
    [Google Scholar]
  17. Gelenczei E. F., Marty E. W.. 1965; Strain stability and immunologic characteristics of a tissue-culture-modified infectious laryngotracheitis virus. Avian Dis9:44–56[PubMed][CrossRef]
    [Google Scholar]
  18. Guy J. S., Barnes H. J., Morgan L. M.. 1990; Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Dis34:106–113[PubMed][CrossRef]
    [Google Scholar]
  19. Han M. G., Kweon C. H., Mo I. P., Kim S. J.. 2002; Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene. Arch Virol147:1017–1031 [CrossRef][PubMed]
    [Google Scholar]
  20. Helferich D., Veits J., Teifke J. P., Mettenleiter T. C., Fuchs W.. 2007; The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. J Gen Virol88:732–742 [CrossRef][PubMed]
    [Google Scholar]
  21. Johnson D. I., Vagnozzi A., Dorea F., Riblet S. M., Mundt A., Zavala G., García M.. 2010; Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Avian Dis54:1251–1259 [CrossRef][PubMed]
    [Google Scholar]
  22. Kawaguchi T., Nomura K., Hirayama Y., Kitagawa T.. 1987; Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res47:4460–4464[PubMed]
    [Google Scholar]
  23. Livak K. J., Schmittgen T. D.. 2001; Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods25:402–408 [CrossRef][PubMed]
    [Google Scholar]
  24. Mahmoudian A., Markham P. F., Noormohammadi A. H., Browning G. F.. 2012; Kinetics of transcription of infectious laryngotracheitis virus genes. Comp Immunol Microbiol Infect Dis35:103–115 [CrossRef]
    [Google Scholar]
  25. Marangon S., Busani L.. 2007; The use of vaccination in poultry production. Rev Sci Tech26:265–274
    [Google Scholar]
  26. Mashchenko A., Riblet S. M., Zavala G., García M.. 2013; In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus. Avian Dis57:523–531 [CrossRef][PubMed]
    [Google Scholar]
  27. Menendez K. R., García M., Spatz S., Tablante N. L.. 2014; Molecular epidemiology of infectious laryngotracheitis: a review. Avian Pathol43:108–117 [CrossRef][PubMed]
    [Google Scholar]
  28. Mundt A., Mundt E., Hogan R. J., García M.. 2011; Glycoprotein J of infectious laryngotracheitis virus is required for efficient egress of infectious virions from cells. J Gen Virol92:2586–2589 [CrossRef][PubMed]
    [Google Scholar]
  29. Oldoni I., Rodríguez-Avila A., Riblet S. M., Zavala G., García M.. 2009; Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States. Avian Pathol38:47–53 [CrossRef][PubMed]
    [Google Scholar]
  30. Pavlova S. P., Veits J., Keil G. M., Mettenleiter T. C., Fuchs W.. 2009; Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine27:773–785 [CrossRef][PubMed]
    [Google Scholar]
  31. Pavlova S. P., Veits J., Blohm U., Maresch C., Mettenleiter T. C., Fuchs W.. 2010; In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. J Gen Virol91:847–857 [CrossRef][PubMed]
    [Google Scholar]
  32. Robertson G. M.. 1977; The role of bursa-dependent responses in immunity to infectious laryngotracheitis. Res Vet Sci22:281–284[PubMed]
    [Google Scholar]
  33. Rodríguez-Avila A., Oldoni I., Riblet S., García M.. 2007; Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines. Avian Dis51:905–911 [CrossRef][PubMed]
    [Google Scholar]
  34. Samberg Y., Aronovici I.. 1969; The development of a vaccine against avian infectious laryngotracheitis. I. modification of a layngotracheitís virus. RefuahVeterinarith 26:54–59
    [Google Scholar]
  35. Samberg Y., Cuperstein E., Bendheim U., Aronovici I.. 1971; The development of a vaccine against avian infectious laryngotracheitis IV. immunization of chickens with a modified laryngotracheitis vaccine in the drinking water. Avian Dis15:413–417[PubMed][CrossRef]
    [Google Scholar]
  36. Schneider C. A., Rasband W. S., Eliceiri K. W.. 2012; NIH Image to ImageJ: 25 years of image analysis. Nat Methods9:671–675 [CrossRef][PubMed]
    [Google Scholar]
  37. Schnitzlein W. M., Winans R., Ellsworth S., Tripathy D. N.. 1995; Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology209:304–314 [CrossRef][PubMed]
    [Google Scholar]
  38. Tong G. Z., Zhang S. J., Wang L., Qiu H. J., Wang Y. F., Wang M., Meng S.. 2001; Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol30:143–148 [CrossRef][PubMed]
    [Google Scholar]
  39. Vagnozzi A., Zavala G., Riblet S. M., Mundt A., García M.. 2012a; Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens. Avian Pathol41:21–31 [CrossRef]
    [Google Scholar]
  40. Vagnozzi A., Riblet S. M., Zavala G., García M.. 2012b; Optimization of a duplex real-time PCR method for relative quantitation of infectious laryngotracheitis virus. Avian Dis56:406–410[CrossRef]
    [Google Scholar]
  41. Vagnozzi A., Riblet S. M., Williams S. M., Zavala G., García M.. 2015; Infection of broilers with two virulent strains of infectious laryngotracheitis virus: criteria for evaluation of experimental infections. Avian Dis59:394–399 [CrossRef][PubMed]
    [Google Scholar]
  42. Veits J., Mettenleiter T. C., Fuchs W.. 2003a; Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture. J Gen Virol84:1415–1425[CrossRef]
    [Google Scholar]
  43. Veits J., Luschow D., Kindermann K., Werner O., Teifke J. P., Mettenleiter T. C., Fuchs W.. 2003b; Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol84:3343–3352[CrossRef]
    [Google Scholar]
  44. Volkening J. D., Spatz S. J.. 2009; Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation. JVirol Methods157:55–61 [CrossRef][PubMed]
    [Google Scholar]
  45. Zhao D., Peng D., Li L., Zhang Q., Zhang C., Petherbridge L., Smith L. P., Baigent S.. 2008; Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection. Virol J5: 19 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000521
Loading
/content/journal/jgv/10.1099/jgv.0.000521
Loading

Data & Media loading...

Supplements

Supplementary File 1

WORD

Supplementary File 2

WORD

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error